Tag: Health Costs
Increase in Brand-Name Drug Cost Mainly Due to Existing Drugs
Rising costs of oral, injectable generic and specialty drugs mostly driven by new product entry
Costs Higher for Those With Comorbid Noncommunicable Diseases
Health expenditure greater for person with two diseases simultaneously than for the diseases separately
Screening Donated Blood for Zika Not Cost-Effective
Universal mini-pool nucleic acid testing only during high mosquito activity cost-effective in Puerto Rico
Many Adults in 50s, Early 60s Worried About Health Insurance
More than one-quarter have little or no confidence they can afford health insurance over the next year
Price of Alirocumab Would Have to Be Cut to Be Cost-Effective
Price of alirocumab would have to decrease from original cost of $14,560 to $1,974 to be cost-effective
Comprehensive Care for Joint Replacement Model Cuts Costs
Institutional spending decreased more in hospitals in treatment areas versus control areas
Universal Vaccination for MenB at College Entry Not Cost-Effective
Incremental cost per quality-adjusted life-year gained $13.8 million under societal perspective
Continuity of Care Tied to Lower Expenditures, Hospitalization
Expenditures lower for those cared for by docs in highest quintile of Bice-Boxerman continuity score
2017 Saw Slowing in National Health Care Spending
Slower growth in health care spending mainly due to use and intensity of goods and services
Cost-Related Insulin Underuse May Affect One in Four Patients
Patients reporting cost-related underuse more likely to have poor glycemic control
